Barclays raised the firm’s price target on GE HealthCare (GEHC) to $87 from $86 and keeps an Equal Weight rating on the shares. The company reported a solid Q4 beat and set its 2026 outlook above the Street,the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GEHC:
- GE HealthCare price target raised to $98 from $95 at Stifel
- GE HealthCare Earnings Call: Growth Amid Tariff Strain
- GE HealthCare price target raised to $85 from $80 at Morgan Stanley
- Morning Movers: Eli Lilly rises, Boston Scientific falls after quarterly results
- GE HealthCare reports Q4 adjusted EPS $1.44, consensus $1.40